Compared to patients without HLA-A*2402  what was the result of patients with HLA-A*2402  on The 3-year elapse-free survival (RFS) in metastatic colorectal cancer (CRC) - stage IIIb?
There was no significant difference in OS between HLA-A*2402 matched and unmatched stage IIIb CRC groups.